BiomarkerLipids & Lipoproteins

Omega-3 Index

EPA + DHA as a share of red-cell membranes

Last reviewed: July 2026
Version: 1.0
Review cadence: Annually

Overview

The Omega-3 Index measures EPA and DHA as a percentage of the fatty acids in red blood cell membranes — a stable, longer-term reflection of omega-3 status than a single blood-fat measurement.

Why it matters

A low Omega-3 Index is associated with higher cardiovascular risk in observational studies, and omega-3 status is often proposed as relevant to brain health. The critical caveat: randomized supplementation trials have generally NOT shown prevention of cognitive decline, and cardiovascular results have been mixed — so it is best understood as a status marker, not a proven target.

Start Here

New to this? Read these first

Typical Journey

How this usually unfolds

Measure it
Understand your result
See what raises and lowers it
Apply evidence-based interventions
Recheck on your review cadence

An orientation to how this topic is typically approached — not medical advice.

Optimal Range

Where the evidence points

An index of ~8% or above is commonly proposed as desirable; below ~4% is considered low. These thresholds come from observational work, not outcome trials.

The proposed targets are association-derived. Raising the index with supplements has not reliably produced the outcomes the association predicts.

Clinical interpretation

A low index indicates low EPA/DHA intake or status and can prompt dietary change (oily fish). It should not be read as a validated treatment target — supplementing to raise it has not been shown to prevent cognitive decline, and cardiovascular trial results are mixed.

What raises and lowers it

Raises it

Oily fish intake (the food-first route)
EPA/DHA supplementation
Higher-dose prescription EPA (clinical contexts)

Lowers it

Low fish/omega-3 intake
High omega-6-dominant dietary patterns (relative effect)

Related Evidence

How this connects across BioSignal

Related conditions

Related pharmaceuticals

Prescription EPA (icosapent ethyl) in selected patients

Related lifestyle interventions

Oily fish 1–2×/week
Dietary pattern quality

Diagnostics

Red-cell fatty-acid analysis (specialty labs)

Frequently asked questions

Should I supplement to raise my Omega-3 Index?

Eating oily fish is sensible regardless. But raising the index with supplements has not been shown to prevent cognitive decline, and cardiovascular trial results are mixed — so treat it as a status marker, not a proven target to chase.

Evidence summary

The Omega-3 Index is a validated status marker with consistent observational associations, but randomized supplementation has largely failed to deliver the predicted cognitive and (in replete populations) cardiovascular benefits — a clear association-versus-causation gap.

References & sources

VITAL trial (omega-3 arm)
Omega-3 Index methodology literature (Harris)
Omega-3 cardiovascular trial meta-analyses

Sources are named authoritative guidelines and scientific bodies. Biomarker pages present established clinical context; calibrated evidence verdicts on specific interventions live in the linked Signal Records.

Educational information — not medical advice

Reference ranges and interpretation vary by laboratory, assay, age, and individual. Use this to understand the science, then interpret your own results with a qualified clinician. See our Medical Disclaimer.

Is this biomarker page clear, accurate, and useful? Your feedback shapes what we review next.

Give feedback